Safety and efficacy of rimegepant orally disintegrating tablet for the acute treatment of migraine in China and South Korea: a phase 3, double-blind, randomised, placebo-controlled trial

Authors: Yu et al.

Lancet Neurol. 2023 Jun;22(6):476-484.

PMID: 37210098 | DOI: 10.1016/S1474-4422(23)00126-6

See related comment.

Sign Up For An MSC Newsletter

Register to Watch the MSC Emerging Science Contest!

The MSC Emerging Science Contest for Young Investigators will take place on Wednesday, December 13, 2023, from 8-10 PM Eastern (US) time. We welcome those who wish to watch the event as an attendee. Register here to attend, and learn more about the contest here.

Discussion

Search

  • Content Types

  • Paper Categories

  • Paper Dates

Paper Categories

By Date